Quantitative detection of specific nucleic acid sequences using lambdoid bacteriophages linked by oligonucleotides to solid support
AssigneeHybridon, Inc.
InventorsBryan L. Ray, Edmund C. C. Lin
Life of this patent
Estimating the term…
Loading patent…
AssigneeHybridon, Inc.
InventorsBryan L. Ray, Edmund C. C. Lin
Estimating the term…
The present invention provided compositions, methods and kits for detection and quantitation of pathogenic organisms. The composition of the invention is an oligonucleotide probe comprising a bacteriophage covalently linked to one site on an oligonucleotide probe complementary to a conserved region of a pathogenic organism. At a second site, the oligonucleotide probe is linked to a matrix. The oligonucleotide probe contains a region complementary to one strand of a restriciton endonuclease recognition site or an oligoribonucleotide moiety. The number of pathogenic organisms present in a biological fluid sample may be quantitated in accordance with the method of the invention by combining the composition of the invention with the sample, allowing hybridization to occur. Hybridization generates a DNA-RNA hybrid, and by adding the appropriate nucleolytic enzyme capable of cleaving DNA-RNA hybrids; bacteriophage will be released for measurement. The kit of the invention provides components which allow the method of the invention to be performed.
A method for quantitating a pathogenic organism in a biological fluid, the pathogenic organism being characterized by a double stranded deoxyribonucleic acid genome, which method comprises:
A method for quantitating a pathogenic organism in a biological fluid, the pathogenic organism being characterized by a double stranded deoxyribonucleic acid genome, which method comprises:
A method for quantitating a pathogenic organism in a biological fluid, the pathogenic organism being characterized by a double stranded deoxyribonucleic acid genome, which method comprises:
A method for quantitating a pathogenic organism in a biological fluid, the pathogenic organism being characterized by a double stranded deoxyribonucleic acid genome, which method comprises:
A method for quantitating a pathogenic organism in a biological fluid, the pathogenic organism being characterized by a double stranded deoxyribonucleic acid genome, which method comprises:
Dependencies are inferred from the claim text.